Anal cancer maximum F-18 fluorodeoxyglucose uptake on positron emission tomography is correlated with prognosis

Radiotherapy and Oncology

Volumn 95, Issue 3, 2010, Pages 288-291

  Kidd, Elizabeth A ^a   Dehdashti, Farrokh ^b,c   Siegel, Barry A ^b,c   Grigsby, Perry W ^a,b,c  

^a Department of Radiation Oncology ^*

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c USA   (United States)

Author keywords

Anal cancer; F 18 fluorodeoxyglucose; Positron emission tomography; Prognosis; Standardized uptake value

Indexed keywords

CAPECITABINE; CISPLATIN; ETOPOSIDE; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; MITOMYCIN C;

ADULT; AGED; ANUS CANCER; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; RADIATION ABSORPTION; RADIOBIOLOGY; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ANUS NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS;

EID: 77952581144     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2010.02.019     Document Type: Article

References (35)

1. Johnson L.G., Madeleine M.M., Newcomer L.M., Schwartz S.M., and Daling J.R. Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000. Cancer 101 (2004) 281-288
2. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2008. CA. Cancer J Clin 58 (2008) 71-96
3. Cotter S.E., Grigsby P.W., Siegel B.A., et al. FDG-PET/CT in the evaluation of anal carcinoma. Int J Radiat Oncol Biol Phys 65 (2006) 720-725
4. Nguyen B.T., Joon D.L., Khoo V., et al. Assessing the impact of FDG-PET in the management of anal cancer. Radiother Oncol 87 (2008) 376-382
5. Yamada K., Brink I., Bisse E., Epting T., and Engelhardt R. Factors influencing [F-18] 2-fluoro-2-deoxy-d-glucose (F-18 FDG) uptake in melanoma cells: the role of proliferation rate, viability, glucose transporter expression and hexokinase activity. J Dermatol 32 (2005) 316-334
6. Sachs S., Bilfinger T.V., Komaroff E., and Franceschi D. Increased standardized uptake value in the primary lesion predicts nodal or distant metastases at presentation in lung cancer. Clin Lung Cancer 6 (2005) 310-313
7. Pillot G., Siegel B.A., and Govindan R. Prognostic value of fluorodeoxyglucose positron emission tomography in non-small cell lung cancer: a review. J Thorac Oncol 1 (2006) 152-159
8. Downey R.J., Akhurst T., Gonen M., et al. Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection. J Clin Oncol 22 (2004) 3255-3260
9. Rizk N., Downey R.J., Akhurst T., et al. Preoperative 18[F]-fluorodeoxyglucose positron emission tomography standardized uptake values predict survival after esophageal adenocarcinoma resection. Ann Thorac Surg 81 (2006) 1076-1081
10. Sasaki R., Komaki R., Macapinlac H., et al. [18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer. J Clin Oncol 23 (2005) 1136-1143
11. Allal A.S., Slosman D.O., Kebdani T., Allaoua M., Lehmann W., and Dulguerov P. Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-d-glucose. Int J Radiat Oncol Biol Phys 59 (2004) 1295-1300
12. Choi J.Y., Jang H.J., Shim Y.M., et al. 18F-FDG PET in patients with esophageal squamous cell carcinoma undergoing curative surgery: prognostic implications. J Nucl Med 45 (2004) 1843-1850
13. Lee S.W., Nam S.Y., Im K.C., et al. Prediction of prognosis using standardized uptake value of 2-[(18)F]fluoro-2-deoxy-d-glucose positron emission tomography for nasopharyngeal carcinomas. Radiother Oncol 87 (2008) 211-216
14. Berghmans T., Dusart M., Paesmans M., et al. Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project. J Thorac Oncol 3 (2008) 6-12
15. Kidd E.A., Siegel B.A., Dehdashti F., and Grigsby P.W. The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival. Cancer 110 (2007) 1738-1744
16. Zbar A.P., Fenger C., Efron J., Beer-Gabel M., and Wexner S.D. The pathology and molecular biology of anal intraepithelial neoplasia: comparisons with cervical and vulvar intraepithelial carcinoma. Int J Colorectal Dis 17 (2002) 203-215
17. Nigro N.D., Vaitkevicius V.K., and Considine Jr. B. Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum 17 (1974) 354-356
18. Flam M., John M., Pajak T.F., et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol 14 (1996) 2527-2539
19. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research. Lancet 1996;348:1049-54.
20. Bartelink H., Roelofsen F., Eschwege F., et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 15 (1997) 2040-2049
21. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. JAMA 53 (1958) 457-481
22. Ajani J.A., Winter K.A., Gunderson L.L., et al. Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. JAMA 299 (2008) 1914-1921
23. Myerson R.J., Kong F., Birnbaum E.H., et al. Radiation therapy for epidermoid carcinoma of the anal canal, clinical and treatment factors associated with outcome. Radiother Oncol 61 (2001) 15-22
24. Akbari R.P., Paty P.B., Guillem J.G., et al. Oncologic outcomes of salvage surgery for epidermoid carcinoma of the anus initially managed with combined modality therapy. Dis Colon Rectum 47 (2004) 1136-1144
25. Roohipour R., Patil S., Goodman K.A., et al. Squamous-cell carcinoma of the anal canal: predictors of treatment outcome. Dis Colon Rectum 51 (2008) 147-153
26. Schwarz J.K., Siegel B.A., Dehdashti F., Myerson R.J., Fleshman J.W., and Grigsby P.W. Tumor response and survival predicted by post-therapy FDG-PET/CT in anal cancer. Int J Radiat Oncol Biol Phys 71 (2008) 180-186
27. Schiller D.E., Cummings B.J., Rai S., et al. Outcomes of salvage surgery for squamous cell carcinoma of the anal canal. Ann Surg Oncol 14 (2007) 2780-2789
28. Chapet O., Gerard J.P., Riche B., Alessio A., Mornex F., and Romestaing P. Prognostic value of tumor regression evaluated after first course of radiotherapy for anal canal cancer. Int J Radiat Oncol Biol Phys 63 (2005) 1316-1324
29. http://www.nccn.org/professionals/physician_gls/PDF/anal.pdf.
30. Das P., Bhatia S., Eng C., et al. Predictors and patterns of recurrence after definitive chemoradiation for anal cancer. Int J Radiat Oncol Biol Phys 68 (2007) 794-800
31. Renehan A.G., Saunders M.P., Schofield P.F., and O'Dwyer S.T. Patterns of local disease failure and outcome after salvage surgery in patients with anal cancer. Br J Surg 92 (2005) 605-614
32. Chapet O., Gerard J.P., Mornex F., et al. Prognostic factors of squamous cell carcinoma of the anal margin treated by radiotherapy: the Lyon experience. Int J Colorectal Dis 22 (2007) 191-199
33. Cummings B.J., Keane T.J., O'Sullivan B., Wong C.S., and Catton C.N. Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C. Int J Radiat Oncol Biol Phys 21 (1991) 1115-1125
34. Xue F., Lin L.L., Dehdashti F., Miller T.R., Siegel B.A., and Grigsby P.W. F-18 fluorodeoxyglucose uptake in primary cervical cancer as an indicator of prognosis after radiation therapy. Gynecol Oncol 101 (2006) 147-151
35. Frisch M., Fenger C., Van den Brule A.J., et al. Variants of squamous cell carcinoma of the anal canal and perianal skin and their relation to human papillomaviruses. Cancer Res 59 (1999) 753-757